Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multifactorial Determinants of Refractory Breathlessness in COPD: Development of the Refractory Breathlessness Score for Risk Stratification.

International journal of chronic obstructive pulmonary disease·2026

Same author

Impact of race-neutral GLI reference equations in Northeast Asian patients with IPF.

BMJ open respiratory research·2026

Same author

Recurrent intracranial hemorrhage without brain metastasis after VEGFR TKI rechallenge in metastatic renal cell carcinoma: a case report and literature review.

Frontiers in oncology·2026

Same author

Efficacy and Safety Profile of a Triple Single-Pill Combination of Valsartan/Amlodipine/Chlorthalidone in Patients with Uncontrolled Hypertension.

Clinical therapeutics·2026

Same author

Predicting climate-driven habitat shifts of Varroa destructor using MaxEnt and CMIP6 data.

Scientific reports·2026

Same author

Impact of Atrial Fibrillation Pattern on Edoxaban Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease: A Secondary Analysis of the EPIC-CAD Randomized Clinical Trial.

Journal of the American Heart Association·2026

Search research articles

Related Experiment Video

Updated: Mar 7, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

Longitudinal changes in lung hyperinflation in COPD.

Jimyung Park¹, Chang-Hoon Lee¹, Yeon Joo Lee²

¹Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul.

International Journal of Chronic Obstructive Pulmonary Disease

|February 23, 2017

Summary

Lung hyperinflation in COPD patients varies significantly over time. Progression of hyperinflation, linked to exacerbations, correlates with a faster decline in forced expiratory volume in 1 second (FEV₁).

Keywords:

chronic obstructive cohort studies forced expiratory volume lung volume measurements pulmonary disease

More Related Videos

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Published on: April 12, 2024

Measurement of the Pressure-volume Curve in Mouse Lungs

Measurement of the Pressure-volume Curve in Mouse Lungs

Published on: January 27, 2015

Related Experiment Videos

Last Updated: Mar 7, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function

Published on: April 12, 2024

Measurement of the Pressure-volume Curve in Mouse Lungs

Measurement of the Pressure-volume Curve in Mouse Lungs

Published on: January 27, 2015

Area of Science:

Pulmonary Medicine
Respiratory Physiology

Background:

Chronic Obstructive Pulmonary Disease (COPD) is marked by accelerated decline in FEV₁ and lung hyperinflation.
Lung hyperinflation is a key characteristic of COPD, yet longitudinal data on its changes and association with FEV₁ decline are limited.

Purpose of the Study:

To analyze longitudinal changes in lung hyperinflation among COPD patients.
To investigate the relationship between lung hyperinflation progression and FEV₁ decline.

Main Methods:

Prospective cohort study of 176 COPD patients with annual lung volume measurements over 5+ years.
Random coefficient modeling used to assess annual lung volume changes and associated factors.
Correlation analysis between changes in lung hyperinflation and FEV₁ decline.

Main Results:

Significant annual declines observed in Residual Volume (RV), Inspiratory Capacity (IC), and Total Lung Capacity (TLC).
RV/TLC and IC/TLC showed variable annual changes, with RV/TLC increasing in 40.3% of patients.
Increased RV/TLC and frequent exacerbations were associated with a faster FEV₁ decline.

Conclusions:

Lung hyperinflation exhibits considerable inter-patient variability in COPD.
Progression of lung hyperinflation is linked to frequent exacerbations and accelerated FEV₁ decline in COPD patients.